Filament Health Corp. (FLHLF)
Filament Health Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Burnaby, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $26,179. On trailing twelve-month figures it carries a trailing P/E of -1.89, a net margin of -543.9%. Its beta of 0.72 implies it has historically moved less than the broad market.
Filament Health Corp. is a pioneering company dedicated to the discovery and extraction of natural psychedelic compounds. Its operations encompass the cultivation of psychedelic plants, genetic research, advanced extraction methodologies, and the conduct of internal clinical trials. Furthermore, the firm licenses its intellectual property and potential drug substances to pharmaceutical developers, scientific researchers, and other authorized entities. The company's principal office is located in Vancouver, Canada.
Filament Health Corp. is most often compared with the following Healthcare names: